Remove BioTech Remove Medical Billing Remove Patient Experience Remove Study
article thumbnail

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

Note that hospitals garnered only about one-half of people in this study, and pharma and health plans fell to one-third of Americans’ responses to the question. Was this due to the growing experience and reporting of surprise medical bills? The media coverage of hospitals suing patients for late payments?

BioTech 160
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 160
article thumbnail

The Hospital CFO in the Anxiety Economy – My Talk at Cerner’s Now/Next Conference

Health Populi

As patients have taken on more financial responsibility for first-dollar costs in high-deductible health plans and medical bills, hospitals and health care providers face growing fiscal pressures for late payments and bad debt. over-the-counter drugs and personal care), biotech, pharma, and health insurance.